Events Archives - Page 92 of 128

1 minute read

Aridis Pharmaceuticals To Discuss Topline Data From Phase 3 Study Of AR-301 During Corporate Update Call On January 25

December 28, 9:35 AM

Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, will host a conference

ARDS

1 minute read

Events
News

ProQR Announces Conference Call To Discuss Axiomer RNA Editing Platform

By Benzinga Newsdesk

December 22, 7:16 AM

ProQR Therapeutics N.V. (NASDAQ:PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced that ProQR management will host an investor conference call and webcast to

PRQR

2 minute read

Verona Pharma To Announce Top-line Data From Phase 3 ENHANCE-1 Trial Of Nebulized Ensifentrine For COPD On Tuesday, December 20, 2022

By Benzinga Newsdesk

December 19, 5:02 PM

Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces it will report top-line Phase 3 data from its

VRNA

2 minute read

Energy Caucus Congressman Scoops Up Shares In 2 High Yielding Pipeline Stocks

By Robert Kuczmarski

December 19, 12:24 PM

Energy stocks have been on a tear since giving up their August gains, they have now returned to October’s trading levels, as the SPDR Select Sector Fund - Energy Select Sector (ARCA: XLE) is down over 6% in the past month.

DVN

2 minute read

3 Consumer Staples Stocks Paying Solid Dividends May Protect Your Portfolio During Downturn

By Robert Kuczmarski

December 19, 10:15 AM

During times of recession or high inflation, people will still need to purchase everyday necessities such as food, cleaning supplies, and hygiene products.

CLX

2 minute read

Zai Lab Presents Interim Overall Survival Data For ZEJULA From The NORA Phase 3 Study At The ESMO Virtual Plenary

By Benzinga Newsdesk

December 15, 5:08 PM

Median overall survival (mOS) was numerically longer for patients receiving ZEJULA regardless of biomarker status, at 46.3 months compared to 43.4 months in the placebo group - No new safety

ZLAB

6 minute read

Pharming Announces Interim Analysis Data From Open-Label Extension Study Of Leniolisib In Presentation At The 64th American Society Of Hematology Annual Meeting And Exposition

By Benzinga Newsdesk

December 15, 2:05 AM

V. Koneti Rao, MD, shared new evidence of long-term safety and hematologic response in patients who received leniolisib to treat APDS, a rare primary immunodeficiency Interim analysis demonstrated leniolisib to be

PHAR

3 minute read

EXCLUSIVE: How Vayner3 Has Helped Connect Web3 Communities — And A Look At Brands That Are Doing It Right

By Chris Katje

December 14, 6:16 PM

The transformation from Web2 to Web3 is bringing big brands into the emerging sector. The power of brands and communities was among the topics covered at Benzinga’s inaugural Future of Crypto event in New York City. Here’s what industry experts have to say on the topics.

SBUX

2 minute read

These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022

By Robert Kuczmarski

December 14, 4:56 PM

Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global.

NHI

2 minute read

The Best In eSports In 2022: Riot Games, ‘Valorant’ And All Of The Winners Of The eSports Awards 2022

By Franca Quarneti

December 14, 3:36 PM

The Esports Awards 2022, one of the most important award shows of the electronic sports industry, have left us with a selection of the best individuals and organizations in this growing scene.

TCEHY